biocore

Poniard Pharmaceuticals: Platinum Rediscovered (Part II)

Hey Ohad, Been following your articles with great pleasure. I like the way you combine basic science and finance. I'm a PhD student in a structural biology lab and also plan to combine the two fields in the future.
I am also long EXEL ( as well as SGEN and SNTA) and I would love to read your thoughts on it. I think many EXEL shareholders that are currently in the red with their investment are looking for reasons to hold on. I am sure they would all appreicate your depth analysis of the company and why you are still bullish on it.


looking forward
M.T